The nuclear receptor ERβ engages AGO2 in regulation of gene transcription, RNA splicing and RISC loading

[1]  Luciano Milanesi,et al.  iSmaRT: a toolkit for a comprehensive analysis of small RNA‐Seq data , 2017, Bioinform..

[2]  Ning Li,et al.  Identification of upstream transcription factors (TFs) for expression signature genes in breast cancer , 2017, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

[3]  G. Greene,et al.  Capture of associated targets on chromatin links long-distance chromatin looping to transcriptional coordination , 2016, Nature Communications.

[4]  C. Guda,et al.  Integrative exploration of genomic profiles for triple negative breast cancer identifies potential drug targets , 2016, Medicine.

[5]  Marco Masseroli,et al.  MuSERA: Multiple Sample Enriched Region Assessment , 2016, Briefings Bioinform..

[6]  J. Gustafsson,et al.  ERβ decreases the invasiveness of triple-negative breast cancer cells by regulating mutant p53 oncogenic function , 2016, Oncotarget.

[7]  E. Chowdhury,et al.  Cadherins: The Superfamily Critically Involved in Breast Cancer. , 2016, Current pharmaceutical design.

[8]  R. Elkon,et al.  Functional genetic screens for enhancer elements in the human genome using CRISPR-Cas9 , 2016, Nature Biotechnology.

[9]  José A. Dianes,et al.  2016 update of the PRIDE database and its related tools , 2016, Nucleic Acids Res..

[10]  Jun Yu,et al.  International Journal of Molecular Sciences the Tead Family and Its Oncogenic Role in Promoting Tumorigenesis , 2022 .

[11]  M. Kruhlak,et al.  Cell Type- and Tissue Context-dependent Nuclear Distribution of Human Ago2* , 2015, The Journal of Biological Chemistry.

[12]  Margaret Warner,et al.  Estrogen receptors in breast carcinogenesis and endocrine therapy , 2015, Molecular and Cellular Endocrinology.

[13]  C. Brancolini,et al.  The MEF2–HDAC axis controls proliferation of mammary epithelial cells and acini formation in vitro , 2015, Journal of Cell Science.

[14]  Y. Wong,et al.  Association of activated Gαq to the tumor suppressor Fhit is enhanced by phospholipase Cβ , 2015, BMC Cancer.

[15]  G. Wahl,et al.  Sox10 Regulates Stem/Progenitor and Mesenchymal Cell States in Mammary Epithelial Cells. , 2015, Cell reports.

[16]  Z. Jehan,et al.  ALK alteration is a frequent event in aggressive breast cancers , 2015, Breast Cancer Research.

[17]  Jason I. Herschkowitz,et al.  Expression profiling of in vivo ductal carcinoma in situ progression models identified B cell lymphoma-9 as a molecular driver of breast cancer invasion , 2015, Breast Cancer Research.

[18]  Ching-Seng Ang,et al.  FunRich: An open access standalone functional enrichment and interaction network analysis tool , 2015, Proteomics.

[19]  Hwa-Yong Lee,et al.  Blockade of Wnt/β-catenin signaling suppresses breast cancer metastasis by inhibiting CSC-like phenotype , 2015, Scientific Reports.

[20]  Q. Qian,et al.  Argonaute 2: A Novel Rising Star in Cancer Research , 2015, Journal of Cancer.

[21]  M. Baumann,et al.  Identification of cytoplasmic proteins interacting with unliganded estrogen receptor α and β in human breast cancer cells , 2015, Proteomics.

[22]  Michael Hackenberg,et al.  sRNAtoolbox: an integrated collection of small RNA research tools , 2015, Nucleic Acids Res..

[23]  C. Scafoglio,et al.  Estrogen receptor beta impacts hormone-induced alternative mRNA splicing in breast cancer cells , 2015, BMC Genomics.

[24]  Denis Thieffry,et al.  RSAT 2015: Regulatory Sequence Analysis Tools , 2015, Nucleic Acids Res..

[25]  Mark S. Anderson,et al.  COPA mutations impair ER-Golgi transport and cause hereditary autoimmune-mediated lung disease and arthritis , 2015, Nature Genetics.

[26]  A. Vincent-Salomon,et al.  The calcineurin/NFAT pathway is activated in diagnostic breast cancer cases and is essential to survival and metastasis of mammary cancer cells , 2015, Cell Death and Disease.

[27]  G. Macino,et al.  ARGONAUTE2 cooperates with SWI/SNF complex to determine nucleosome occupancy at human Transcription Start Sites , 2015, Nucleic acids research.

[28]  David Gacquer,et al.  Principles Governing A-to-I RNA Editing in the Breast Cancer Transcriptome , 2015, bioRxiv.

[29]  W. Huber,et al.  Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2 , 2014, Genome Biology.

[30]  S. Fuqua,et al.  Role of MTA2 in human cancer , 2014, Cancer and Metastasis Reviews.

[31]  Hao Zhang,et al.  Molecular functions and significance of the MTA family in hormone-independent cancer , 2014, Cancer and Metastasis Reviews.

[32]  J. Park,et al.  AGO2 and SETDB1 cooperate in promoter-targeted transcriptional silencing of the androgen receptor gene , 2014, Nucleic acids research.

[33]  A. Quinlan.  BEDTools: The Swiss‐Army Tool for Genome Feature Analysis , 2014, Current protocols in bioinformatics.

[34]  Paul Theodor Pyl,et al.  HTSeq—a Python framework to work with high-throughput sequencing data , 2014, bioRxiv.

[35]  Walter Birchmeier,et al.  The BCL9-2 proto-oncogene governs estrogen receptor alpha expression in breast tumorigenesis , 2014, Oncotarget.

[36]  Taras Makhnevych,et al.  Nutritional status modulates box C/D snoRNP biogenesis by regulated subcellular relocalization of the R2TP complex , 2014, Genome Biology.

[37]  Timothy H. Wu,et al.  ChIPseek, a web-based analysis tool for ChIP data , 2014, BMC Genomics.

[38]  E. Izaurralde,et al.  A DDX6-CNOT1 complex and W-binding pockets in CNOT9 reveal direct links between miRNA target recognition and silencing. , 2014, Molecular cell.

[39]  M. Pujana,et al.  PKA signaling drives mammary tumorigenesis through Src , 2014, Oncogene.

[40]  T. Kwon,et al.  Complexity in Regulation of microRNA Machinery Components in Invasive Breast Carcinoma , 2014, Pathology & Oncology Research.

[41]  M. Baumann,et al.  Post-transcriptional Regulation of Human Breast Cancer Cell Proteome by Unliganded Estrogen Receptor β via microRNAs* , 2014, Molecular & Cellular Proteomics.

[42]  E. Cheung,et al.  Estrogen receptor-mediated long-range chromatin interactions and transcription in breast cancer , 2014, Molecular and Cellular Endocrinology.

[43]  Matthias E. Futschik,et al.  UniHI 7: an enhanced database for retrieval and interactive analysis of human molecular interaction networks , 2013, Nucleic Acids Res..

[44]  G. Sledge,et al.  Wnt signaling in triple negative breast cancer is associated with metastasis , 2013, BMC Cancer.

[45]  F. Soares,et al.  Estrogen receptor alpha/beta ratio and estrogen receptor beta as predictors of endocrine therapy responsiveness–a randomized neoadjuvant trial comparison between anastrozole and tamoxifen for the treatment of postmenopausal breast cancer , 2013, BMC Cancer.

[46]  M. Rosenfeld,et al.  LncRNA-Dependent Mechanisms of Androgen Receptor-regulated Gene Activation Programs , 2013, Nature.

[47]  L. Pfeffer,et al.  Comprehensive Analysis of MicroRNA (miRNA) Targets in Breast Cancer Cells* , 2013, The Journal of Biological Chemistry.

[48]  W. Zwart,et al.  PKA phosphorylation redirects ERα to promoters of a unique gene set to induce tamoxifen resistance , 2013, Oncogene.

[49]  Wouter de Laat,et al.  CTCF: the protein, the binding partners, the binding sites and their chromatin loops , 2013, Philosophical Transactions of the Royal Society B: Biological Sciences.

[50]  Caleb Webber,et al.  GAT: a simulation framework for testing the association of genomic intervals , 2013, Bioinform..

[51]  Graziano Pesole,et al.  PscanChIP: finding over-represented transcription factor-binding site motifs and their correlations in sequences from ChIP-Seq experiments , 2013, Nucleic Acids Res..

[52]  M. Blanchette,et al.  Two new and distinct roles for Drosophila Argonaute-2 in the nucleus: alternative pre-mRNA splicing and transcriptional repression. , 2013, Genes & development.

[53]  M. Baumann,et al.  Molecular mechanisms of selective estrogen receptor modulator activity in human breast cancer cells: identification of novel nuclear cofactors of antiestrogen-ERα complexes by interaction proteomics. , 2013, Journal of proteome research.

[54]  M. Rosbash,et al.  Nascent-Seq reveals novel features of mouse circadian transcriptional regulation , 2012, eLife.

[55]  R. Spanjaard,et al.  A small RNA derived from RNA coactivator SRA blocks steroid receptor signaling via inhibition of Pus1p-mediated pseudouridylation of SRA: evidence of a novel RNA binding domain in the N-terminus of steroid receptors. , 2012, Biochemistry.

[56]  P. Kapranov,et al.  Intronic RNAs constitute the major fraction of the non-coding RNA in mammalian cells , 2012, BMC Genomics.

[57]  V. Beneš,et al.  Direct regulation of microRNA biogenesis and expression by estrogen receptor beta in hormone-responsive breast cancer , 2012, Oncogene.

[58]  Annick Harel-Bellan,et al.  Argonaute proteins couple chromatin silencing to alternative splicing , 2012, Nature Structural &Molecular Biology.

[59]  S. Scarlata,et al.  γ-Synuclein Interacts with Phospholipase Cβ2 to Modulate G Protein Activation , 2012, PloS one.

[60]  P. Tarapore,et al.  Estrogen receptor-beta and breast cancer: Translating biology into clinical practice , 2012, Steroids.

[61]  David R. Kelley,et al.  Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks , 2012, Nature Protocols.

[62]  A. Dejean,et al.  Senescence is an endogenous trigger for microRNA-directed transcriptional gene silencing in human cells , 2012, Nature Cell Biology.

[63]  Juw Won Park,et al.  MATS: a Bayesian framework for flexible detection of differential alternative splicing from RNA-Seq data , 2012, Nucleic acids research.

[64]  M. Rosbash,et al.  Nascent-seq indicates widespread cotranscriptional pre-mRNA splicing in Drosophila. , 2011, Genes & development.

[65]  Jianmin Wu,et al.  PINA v2.0: mining interactome modules , 2011, Nucleic Acids Res..

[66]  Ryan K. Dale,et al.  RNAi-independent role for Argonaute2 in CTCF/CP190 chromatin insulator function. , 2011, Genes & development.

[67]  J. Gustafsson,et al.  The different roles of ER subtypes in cancer biology and therapy , 2011, Nature Reviews Cancer.

[68]  Philip Machanick,et al.  MEME-ChIP: motif analysis of large DNA datasets , 2011, Bioinform..

[69]  Arun K. Ramani,et al.  Global impact of RNA polymerase II elongation inhibition on alternative splicing regulation. , 2011, Genome research.

[70]  Lorenzo Ferraro,et al.  Global analysis of estrogen receptor beta binding to breast cancer cell genome reveals an extensive interplay with estrogen receptor alpha for target gene regulation , 2011, BMC Genomics.

[71]  Tao Ye,et al.  seqMINER: an integrated ChIP-seq data interpretation platform , 2010, Nucleic acids research.

[72]  C. Glass,et al.  Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities. , 2010, Molecular cell.

[73]  Terence P. Speed,et al.  Estrogen Receptor β Binds to and Regulates Three Distinct Classes of Target Genes* , 2010, The Journal of Biological Chemistry.

[74]  Atsushi B. Tsuji,et al.  Knockdown of COPA, identified by loss-of-function screen, induces apoptosis and suppresses tumor growth in mesothelioma mouse model. , 2010, Genomics.

[75]  M. Baumann,et al.  Identification of a Hormone-regulated Dynamic Nuclear Actin Network Associated with Estrogen Receptor α in Human Breast Cancer Cell Nuclei* , 2010, Molecular & Cellular Proteomics.

[76]  W. Huber,et al.  which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. MAnorm: a robust model for quantitative comparison of ChIP-Seq data sets , 2011 .

[77]  E. Liu,et al.  An Oestrogen Receptor α-bound Human Chromatin Interactome , 2009, Nature.

[78]  Manuel de la Mata,et al.  Control of alternative splicing through siRNA-mediated transcriptional gene silencing , 2009, Nature Structural &Molecular Biology.

[79]  Michael D. Wilson,et al.  ChIP-seq: using high-throughput sequencing to discover protein-DNA interactions. , 2009, Methods.

[80]  Lior Pachter,et al.  Sequence Analysis , 2020, Definitions.

[81]  Cole Trapnell,et al.  Ultrafast and memory-efficient alignment of short DNA sequences to the human genome , 2009, Genome Biology.

[82]  S. O'toole,et al.  Dysregulation of Hedgehog, Wnt and Notch signalling pathways in breast cancer. , 2009, Histology and histopathology.

[83]  P. Sætrom,et al.  MicroRNA-directed transcriptional gene silencing in mammalian cells , 2008, Proceedings of the National Academy of Sciences.

[84]  Clifford A. Meyer,et al.  Model-based Analysis of ChIP-Seq (MACS) , 2008, Genome Biology.

[85]  P. Kushner,et al.  Estrogen receptor beta increases the efficacy of antiestrogens by effects on apoptosis and cell cycling in breast cancer cells , 2008, Breast Cancer Research and Treatment.

[86]  G. Meister,et al.  The Argonaute protein family , 2008, Genome Biology.

[87]  J. Gustafsson,et al.  A genome-wide study of the repressive effects of estrogen receptor beta on estrogen receptor alpha signaling in breast cancer cells , 2008, Oncogene.

[88]  G. Meister,et al.  Proteomic and functional analysis of Argonaute‐containing mRNA–protein complexes in human cells , 2007, EMBO reports.

[89]  J. Bergh,et al.  Inhibitory effects of estrogen receptor beta on specific hormone-responsive gene expression and association with disease outcome in primary breast cancer , 2007, Breast Cancer Research.

[90]  J. Gutkind,et al.  G-protein-coupled receptors and cancer , 2007, Nature Reviews Cancer.

[91]  J. Frasor,et al.  Impact of Estrogen Receptor β on Gene Networks Regulated by Estrogen Receptor α in Breast Cancer Cells , 2006 .

[92]  D. Corey,et al.  Involvement of AGO1 and AGO2 in mammalian transcriptional silencing , 2006, Nature Structural &Molecular Biology.

[93]  R. Reed,et al.  Functional coupling of RNAP II transcription to spliceosome assembly. , 2006, Genes & development.

[94]  Thomas Werner,et al.  MatInspector and beyond: promoter analysis based on transcription factor binding sites , 2005, Bioinform..

[95]  L. Murphy,et al.  Inducible upregulation of oestrogen receptor-beta1 affects oestrogen and tamoxifen responsiveness in MCF7 human breast cancer cells. , 2005, Journal of molecular endocrinology.

[96]  Nick V Grishin,et al.  Biochemical identification of Argonaute 2 as the sole protein required for RNA-induced silencing complex activity. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[97]  J. M. Thomson,et al.  Argonaute2 Is the Catalytic Engine of Mammalian RNAi , 2004, Science.

[98]  P. Pujol,et al.  Loss of ERbeta expression as a common step in estrogen-dependent tumor progression. , 2004, Endocrine-related cancer.

[99]  T. Tuschl,et al.  Human Argonaute2 mediates RNA cleavage targeted by miRNAs and siRNAs. , 2004, Molecular cell.

[100]  P. Shannon,et al.  Cytoscape: a software environment for integrated models of biomolecular interaction networks. , 2003, Genome research.

[101]  E. Lam,et al.  Expression of estrogen receptor beta isoforms in normal breast epithelial cells and breast cancer: regulation by methylation. , 2003, Oncogene.

[102]  T. Svingen,et al.  Altered HOX Gene Expression in Human Skin and Breast Cancer Cells , 2003, Cancer biology & therapy.

[103]  G. Hager,et al.  Dynamic Shuttling and Intranuclear Mobility of Nuclear Hormone Receptors* , 2003, The Journal of Biological Chemistry.

[104]  A. Wärri,et al.  Involvement of estrogen receptor β in terminal differentiation of mammary gland epithelium , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[105]  Cameron S. Osborne,et al.  Long-range chromatin regulatory interactions in vivo , 2002, Nature Genetics.

[106]  Leslie M. Shaw,et al.  The role of NFAT transcription factors in integrin-mediated carcinoma invasion , 2002, Nature Cell Biology.

[107]  Neil J McKenna,et al.  A Steroid Receptor Coactivator, SRA, Functions as an RNA and Is Present in an SRC-1 Complex , 1999, Cell.

[108]  J. Gustafsson,et al.  Generation and reproductive phenotypes of mice lacking estrogen receptor beta. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[109]  M. Baumann,et al.  Identification of proteins associated with ligand‐activated estrogen receptor α in human breast cancer cell nuclei by tandem affinity purification and nano LC‐MS/MS , 2011, Proteomics.

[110]  Mario Cannataro,et al.  A large set of estrogen receptor β‐interacting proteins identified by tandem affinity purification in hormone‐responsive human breast cancer cell nuclei , 2011, Proteomics.

[111]  K. Claffey,et al.  Argonaute-2 expression is regulated by epidermal growth factor receptor and mitogen-activated protein kinase signaling and correlates with a transformed phenotype in breast cancer cells. , 2009, Endocrinology.

[112]  Martin J. Simard,et al.  Argonaute proteins: key players in RNA silencing , 2008, Nature Reviews Molecular Cell Biology.

[113]  J. Gustafsson,et al.  Ligands differentially modify the nuclear mobility of estrogen receptors alpha and beta. , 2008, Endocrinology.

[114]  K. Morris.  RNA-mediated transcriptional gene silencing in human cells. , 2008, Current topics in microbiology and immunology.

[115]  J. Gustafsson,et al.  Ligands Differentially Modify the Nuclear Mobility of Estrogen Receptors α and β , 2008 .

[116]  Jordan M. Komisarow,et al.  RIP-Chip: the isolation and identification of mRNAs, microRNAs and protein components of ribonucleoprotein complexes from cell extracts , 2006, Nature Protocols.

[117]  J. Frasor,et al.  Impact of estrogen receptor beta on gene networks regulated by estrogen receptor alpha in breast cancer cells. , 2006, Endocrinology.

[118]  C. Watson.  Stat Transcription Factors in Mammary Gland Development and Tumorigenesis , 2004, Journal of Mammary Gland Biology and Neoplasia.